ZyVersa Therapeutics common stock to trade on OTCQB from July 28

ZyVersa Therapeutics, Inc.

OTCQB approval received on July 25, 2025; trading commences July 28 under ticker ZVSA.
Move to OTCQB indicates likely delisting from a senior exchange (e.g., Nasdaq).
No financial terms disclosed; company remains an SEC filer.

item 8.01item 9.01

Source: SEC EDGAR

accession 0001641172-25-021100

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.